Complex interplay between -catenin signalling and Notch effectors in intestinal tumorigenesis
Grégory Peignon(Inserm), Béatrice Romagnolo(Inserm), Isabelle Van Seuningen(Inserm), Wulfran Cacheux(Université de Versailles Saint-Quentin-en-Yvelines), Christine Perret(Centre National de la Recherche Scientifique), Tasuku Honjo(Kyoto University), Noah F. Shroyer(University of Cincinnati Medical Center), Benoît Terris(University of Geneva), Aurélie Durand(Centre National de la Recherche Scientifique), Pierre Laurent‐Puig(Inserm), Olivier Ayrault(St. Jude Children's Research Hospital)
Cited by 145
Related Papers
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
|The Journal of Experimental Medicine|2000|5.2k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|2.9k
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
|New England Journal of Medicine|2003|2.1k